This inventor holds 3 USPTO granted patents and 11 published patent applications and 1 EPO patent. Top assignees: Sanofi, Bayer Aktiengesellschaft. Active years: 2013-2023.
Company Filing History:
Years Active: 2013-2023
Title: The Innovations of Martin Van Eickels
Introduction
Martin Van Eickels is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medicine, particularly in the area of drug administration and cardiovascular health. With a total of 3 patents to his name, Van Eickels has demonstrated a commitment to improving patient care through innovative solutions.
Latest Patents
One of his latest patents focuses on supporting patients in the repeated taking of drugs. This invention relates to a method, system, and computer program product that monitors drug intake by patients. It informs patients, doctors, or caregivers if a drug portion should not be taken, thereby optimizing treatment effectiveness and reducing risks. Another significant patent involves the use of dronedarone for preparing a medicament aimed at preventing cardiovascular hospitalization or mortality. This patent outlines methods for utilizing dronedarone or its pharmaceutically acceptable salts in the development of medications that address serious cardiovascular issues.
Career Highlights
Throughout his career, Martin Van Eickels has worked with prominent companies such as Sanofi and Bayer Aktiengesellschaft. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.
Collaborations
Van Eickels has collaborated with notable professionals in his field, including Davide Radzik and Christophe Gaudin. These partnerships have further enhanced his work and expanded the impact of his inventions.
Conclusion
Martin Van Eickels is a distinguished inventor whose work has the potential to significantly improve patient outcomes in drug administration and cardiovascular health. His innovative patents reflect a deep understanding of medical needs and a commitment to enhancing therapeutic treatments.